{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T22:40:57Z","timestamp":1785451257630,"version":"3.56.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T00:00:00Z","timestamp":1654905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T00:00:00Z","timestamp":1654905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"grants from the Second Medical Centre of Chinese PLA General Hospital"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetes Ther"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s13300-022-01274-4","type":"journal-article","created":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T11:03:03Z","timestamp":1654945383000},"page":"1353-1365","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Blood Glucose Fluctuation in Older Adults with Diabetes Mellitus and End-Stage Renal Disease on Maintenance Hemodialysis: An Observational Study"],"prefix":"10.1007","volume":"13","author":[{"given":"Jinzhu","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiqin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3723-5703","authenticated-orcid":false,"given":"Chunlin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5075-401X","authenticated-orcid":false,"given":"Guang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0264-2627","authenticated-orcid":false,"given":"Xiaoling","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,11]]},"reference":[{"key":"1274_CR1","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/s0140-6736(96)91246-5","volume":"347","author":"P Fiorina","year":"1996","unstructured":"Fiorina P, Lattuada G, Ponari O, Silvestrini C, DallAglio P. Impaired nocturnal melatonin excretion and changes of immunological status in ischaemic stroke patients. Lancet. 1996;347:692\u20133. https:\/\/doi.org\/10.1016\/s0140-6736(96)91246-5.","journal-title":"Lancet"},{"key":"1274_CR2","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/s0079-6123(02)39025-3","volume":"139","author":"KC Abbott","year":"2002","unstructured":"Abbott KC, Bakris GL. Treatment of the diabetes mellitus patient: focus on cardiovascular and renal risk reduction. Prog Brain Res. 2002;139:289\u201398. https:\/\/doi.org\/10.1016\/s0079-6123(02)39025-3.","journal-title":"Prog Brain Res"},{"key":"1274_CR3","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1081\/jdi-100100866","volume":"22","author":"YS Haviv","year":"2000","unstructured":"Haviv YS, Sharkia M, Safadi R. Hypoglycemia in patients with renal failure. Ren Fail. 2000;22:219\u201323. https:\/\/doi.org\/10.1081\/jdi-100100866.","journal-title":"Ren Fail"},{"key":"1274_CR4","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1097\/01.mco.0000172590.32564.b9","volume":"8","author":"V Rigalleau","year":"2005","unstructured":"Rigalleau V, Gin H. Carbohydrate metabolism in uraemia. Curr Opin Clin Nutr Metab Care. 2005;8:463\u20139. https:\/\/doi.org\/10.1097\/01.mco.0000172590.32564.b9.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"1274_CR5","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1093\/ndt\/gfl710","volume":"22","author":"JE Burmeister","year":"2007","unstructured":"Burmeister JE, Scapini A, da Rosa MD, da Costa MG, Campos BM. Glucose-added dialysis fluid prevents asymptomatic hypoglycemia in regular hemodialysis. Nephrol Dial Transplant. 2007;22:1184\u20139. https:\/\/doi.org\/10.1093\/ndt\/gfl710.","journal-title":"Nephrol Dial Transplant"},{"key":"1274_CR6","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1053\/j.ajkd.2006.01.007","volume":"47","author":"M Sangill","year":"2006","unstructured":"Sangill M, Pedersen EB. The effect of glucose added to the dialysis fluid on blood pressure, blood glucose, and quality of life in hemodialysis patients: a placebo-controlled crossover study. Am J Kidney Dis. 2006;47:636\u201343. https:\/\/doi.org\/10.1053\/j.ajkd.2006.01.007.","journal-title":"Am J Kidney Dis"},{"key":"1274_CR7","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1159\/000362863","volume":"38","author":"M Gai","year":"2014","unstructured":"Gai M, Merlo I, Dellepiane S, et al. Glycemic pattern in diabetes mellitus patients on hemodialysis: continuous glucose monitoring (CGM) analysis. Blood Purif. 2014;38:68\u201373. https:\/\/doi.org\/10.1159\/000362863.","journal-title":"Blood Purif"},{"key":"1274_CR8","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1055\/s-0034-1370963","volume":"46","author":"F Chantrel","year":"2014","unstructured":"Chantrel F, Sissoko H, Kepenekian L, et al. Influence of dialysis on the glucose profile in patients with diabetes: usefulness of continuous glucose monitoring. Horm Metab Res. 2014;46:810\u20133. https:\/\/doi.org\/10.1055\/s-0034-1370963.","journal-title":"Horm Metab Res"},{"key":"1274_CR9","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.jdiacomp.2014.12.015","volume":"29","author":"YP Jin","year":"2015","unstructured":"Jin YP, Su XF, Yin GP, et al. Blood glucose fluctuations in hemodialysis patients with end stage diabetes mellitus nephropathy. J Diabetes Complicat. 2015;29:395\u20139. https:\/\/doi.org\/10.1016\/j.jdiacomp.2014.12.015.","journal-title":"J Diabetes Complicat"},{"key":"1274_CR10","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.diabres.2015.01.026","volume":"107","author":"M Joubert","year":"2015","unstructured":"Joubert M, Fourmy C, Henri P, Ficheux M, Lobbedez T, Reznik Y. Effectiveness of continuous glucose monitoring in dialysis patients with diabetes: the DIALYDIAB pilot study. Diabetes Res Clin Pract. 2015;107:348\u201354. https:\/\/doi.org\/10.1016\/j.diabres.2015.01.026.","journal-title":"Diabetes Res Clin Pract"},{"key":"1274_CR11","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.2337\/dc08-1688","volume":"32","author":"S Kazempour-Ardebili","year":"2009","unstructured":"Kazempour-Ardebili S, Lecamwasam VL, Dassanyake T, et al. Assessing glycemic control in maintenance hemodialysis patients with type\u00a02 diabetes. Diabetes Care. 2009;32:1137\u201342. https:\/\/doi.org\/10.2337\/dc08-1688.","journal-title":"Diabetes Care"},{"key":"1274_CR12","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1089\/dia.2010.0052","volume":"12","author":"M Mirani","year":"2010","unstructured":"Mirani M, Berra C, Finazzi S, et al. Inter-day glycemic variability assessed by continuous glucose monitoring in insulin-treated type\u00a02 diabetes patients on hemodialysis. Diabetes Technol Ther. 2010;12:749\u201353. https:\/\/doi.org\/10.1089\/dia.2010.0052.","journal-title":"Diabetes Technol Ther"},{"key":"1274_CR13","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1177\/1932296818818429","volume":"13","author":"K Mori","year":"2019","unstructured":"Mori K, Emoto M, Abe M, Inaba M. Visualization of blood glucose fluctuations using continuous glucose monitoring in patients undergoing hemodialysis. J Diabetes Sci Technol. 2019;13:413\u20134. https:\/\/doi.org\/10.1177\/1932296818818429.","journal-title":"J Diabetes Sci Technol"},{"key":"1274_CR14","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1089\/dia.2010.0067","volume":"12","author":"HS Jung","year":"2010","unstructured":"Jung HS, Kim HI, Kim MJ, et al. Analysis of hemodialysis-associated hypoglycemia in patients with type\u00a02 diabetes using a continuous glucose monitoring system. Diabetes Technol Ther. 2010;12:801\u20137. https:\/\/doi.org\/10.1089\/dia.2010.0067.","journal-title":"Diabetes Technol Ther"},{"key":"1274_CR15","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.1093\/ndt\/gfp181","volume":"24","author":"JP Riveline","year":"2009","unstructured":"Riveline JP, Teynie J, Belmouaz S, et al. Glycaemic control in type\u00a02 diabetes mellitus patients on chronic haemodialysis: use of a continuous glucose monitoring system. Nephrol Dial Transpl. 2009;24:2866\u201371. https:\/\/doi.org\/10.1093\/ndt\/gfp181.","journal-title":"Nephrol Dial Transpl"},{"key":"1274_CR16","doi-asserted-by":"publisher","first-page":"994","DOI":"10.2337\/dc17-0636","volume":"40","author":"R Beck","year":"2017","unstructured":"Beck R, Connor C, Mullen DM, et al. The fallacy of average: how using HbA1c alone to assess glycemic control can be misleading. Diabetes Care. 2017;40:994\u20139. https:\/\/doi.org\/10.2337\/dc17-0636.","journal-title":"Diabetes Care"},{"key":"1274_CR17","doi-asserted-by":"publisher","first-page":"4116","DOI":"10.3390\/jcm10184116","volume":"10","author":"M Divani","year":"2021","unstructured":"Divani M, Georgianos PI, Didangelos T, et al. Assessment of hyperglycemia, hypoglycemia and inter-day glucose variability using continuous glucose monitoring among diabetic patients on chronic hemodialysis. J Clin Med. 2021;10:4116. https:\/\/doi.org\/10.3390\/jcm10184116.","journal-title":"J Clin Med"},{"key":"1274_CR18","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.2337\/dci19-0028","volume":"42","author":"T Battelino","year":"2019","unstructured":"Battelino T, Danne T, Bergenstal RM, et al. Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range. Diabetes Care. 2019;42:1593\u2013603. https:\/\/doi.org\/10.2337\/dci19-0028.","journal-title":"Diabetes Care"},{"issue":"98","key":"1274_CR19","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2020.06.019","volume":"2020","author":"Kidney Disease: Improving Global Outcomes (KIDGO) Diabetes work group. KDIGO","year":"2020","unstructured":"Kidney Disease: Improving Global Outcomes (KIDGO) Diabetes work group. KDIGO. Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease. Kidney Int. 2020;2020(98):S1-115. https:\/\/doi.org\/10.1016\/j.kint.2020.06.019.","journal-title":"Kidney Int"},{"key":"1274_CR20","unstructured":"International Diabetes Federation (2021) IDF Diabetes Atlas, 10th edn. Brussels: IDF. 2021. https:\/\/www.diabetesatlas.org"},{"key":"1274_CR21","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1159\/000485695","volume":"196","author":"N Maruyama","year":"2018","unstructured":"Maruyama N, Abe M. Targets and therapeutics for glycemic control in diabetes patients on hemodialysis. Contrib Nephrol. 2018;196:37\u201343. https:\/\/doi.org\/10.1159\/000485695.","journal-title":"Contrib Nephrol"},{"key":"1274_CR22","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1007\/s00592-021-01699-6","volume":"58","author":"M Gallieni","year":"2021","unstructured":"Gallieni M, De Salvo C, Lunati ME, et al. Continuous glucose monitoring in patients with type\u00a02 diabetes on hemodialysis. Acta Diabetol. 2021;58:975\u201381. https:\/\/doi.org\/10.1007\/s00592-021-01699-6.","journal-title":"Acta Diabetol"},{"key":"1274_CR23","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1111\/j.1464-5491.2008.02565.x","volume":"25","author":"A Ceriello","year":"2008","unstructured":"Ceriello A, Colagiuri S. International Diabetes Federation guideline for management of post meal glucose: a review of recommendations. Diabet Med. 2008;25:1151\u20136. https:\/\/doi.org\/10.1111\/j.1464-5491.2008.02565.x.","journal-title":"Diabet Med"},{"key":"1274_CR24","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1002\/dmrr.613","volume":"22","author":"L Piconi","year":"2006","unstructured":"Piconi L, Quagliaro L, Assaloni R, et al. Constant and intermittent high glucose enhances endothelial cell apoptosis through mitochondrial superoxide overproduction. Diabetes Metab Res Rev. 2006;22:198\u2013203. https:\/\/doi.org\/10.1002\/dmrr.613.","journal-title":"Diabetes Metab Res Rev"},{"key":"1274_CR25","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1111\/j.1464-5491","volume":"27","author":"S Buscemi","year":"2010","unstructured":"Buscemi S, Re A, Batisi JA, et al. Glycaemic variability using continuous glucose monitoring and endothelial function in the metabolic syndrome and in type\u00a02 diabetes. Diabet Med. 2010;27:872\u20138. https:\/\/doi.org\/10.1111\/j.1464-5491.","journal-title":"Diabet Med"},{"key":"1274_CR26","doi-asserted-by":"publisher","first-page":"240","DOI":"10.3346\/jkms.2016.31.2.240","volume":"31","author":"JA Lee","year":"2016","unstructured":"Lee JA, Sunwoo S, Kim YS, et al. The effect of sleep quality on the development of type\u00a02 diabetes in primary care patients. J Korean Med Sci. 2016;31:240\u20136. https:\/\/doi.org\/10.3346\/jkms.2016.31.2.240.","journal-title":"J Korean Med Sci"},{"key":"1274_CR27","doi-asserted-by":"publisher","unstructured":"Workgroup on Hypoglycemia, American Diabetes Association. Defining and reporting hypoglycemia in diabetes: a report from the American diabetes association workgroup on hypoglycemia. Diabetes Care. 2005;28:1245\u20139. https:\/\/doi.org\/10.2337\/diacare.28.5.1245.","DOI":"10.2337\/diacare.28.5.1245"}],"container-title":["Diabetes Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-022-01274-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13300-022-01274-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-022-01274-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T18:17:46Z","timestamp":1656440266000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13300-022-01274-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,11]]},"references-count":27,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["1274"],"URL":"https:\/\/doi.org\/10.1007\/s13300-022-01274-4","relation":{},"ISSN":["1869-6953","1869-6961"],"issn-type":[{"value":"1869-6953","type":"print"},{"value":"1869-6961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,11]]},"assertion":[{"value":"23 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}